V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Mid
U
URGNAI Stock Diagnostic Report

UroGen to invest up to $7M in IntraGel as part of an option agreement

UroGen Pharma has agreed to invest up to $7 million in IntraGel Therapeutics as part of an oncology field option agreement.

View Source Article ↗
AI CATALYST SCORE75 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

URGN Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-08-20 11:35:38URGN75MidView Report →
2026-08-20 11:09:05URGN75MidView Report →
2026-08-05 18:35:27URGN78MidView Report →
View Full History for URGN (Blueprint) →